Reuters features IPOX® Associate Lukas Muehlbauer’s commentary on York Space Systems’ $4.75 billion NYSE debut. Muehlbauer notes that the successful listing signals a receptive market for defense and space stocks in 2026, setting the stage for the highly anticipated SpaceX IPO. He also analyzes York’s acquisition of ATLAS Space Operations, cautioning that despite the push into software services, the stock will likely remain volatile and sensitive to government spending news in the near term.

Reuters features IPOX® Research Associate Lukas Muehlbauer’s analysis on Eikon Therapeutics' upcoming $908 million IPO. Muehlbauer highlights the premium placed on CEO Roger Perlmutter’s leadership and the company’s Nobel Prize-backed drug discovery platform. He further contrasts Eikon with recent listings like Aktis Oncology, explaining how Eikon aims to overcome historical toxicity challenges in immune-stimulating drugs. This listing signals renewed momentum for the biotech sector following a challenging 2025.

Bloomberg features IPOX® CEO Josef Schuster’s analysis on the "Once Upon a Farm" IPO, co-founded by Jennifer Garner. Discussing the "Hollywood IPO Curse," Schuster warns that celebrity-backed deals historically underperform, citing an "eight out of 11" failure rate. He urges investors to prioritize operational expertise and management resumes over star power. The article underscores the critical importance of evaluating business fundamentals versus celebrity marketing when assessing new public listings.

Reuters reports that Bob's Discount Furniture is targeting a $2.5 billion valuation in its upcoming NYSE IPO. IPOX® VP Kat Liu analyzed the retailer's position regarding trade risks, noting that the company’s shift away from China sourcing helps mitigate specific tariff concerns. However, Liu cautioned that the stock might still experience volatility driven by broader market sentiment regarding freight costs and global trade, rather than direct margin impacts.

Reuters reports that Forgent Power is targeting an $8.8 billion valuation in its upcoming NYSE debut. IPOX® Associate Lukas Muehlbauer provided expert analysis on the listing, characterizing the company’s heavy focus on data centers as a rare "direct play" on AI spending. Muehlbauer noted that while the growth narrative is strong, the proposed 10x price-to-sales ratio asks investors to pay a significant premium over industry peers.